E. Adjuvant Therapies against Brain Tumors

Brain tumors: molecular biology and targeted therapies.

Brain tumors: molecular biology and targeted therapies M. E. Hegi, A. Murat, W. L. Lambiv & R. Stupp Laboratory of Tumor Biology and Genetics, Department of Neurosurgery, University Hospital Lausanne (CHUV), Lausanne; National Center of Competence in Research (NCCR) Molecular Oncology, Swiss Institute of Experimental Cancer Research (ISREC), Epalinges; Multidisciplinary Oncology Center, Univers...

Obesity may protect against benign brain tumors.

Sir, We read with great interest the article by Eby [1]. We agree with the author that ionic zinc content of the lozenges may be one of the factors responsible for the beneficial effect in common cold. Some other relevant negative factors include zinc lozenges producing side-effects and compromising the compliance as well as masking, higher than therapeutic dose of zinc being used in some of th...

Blood-Brain Barrier and Effectiveness of Therapy Against Brain Tumors

Adjuvant Biological Therapies in Chronic Leg Ulcers

Current biological treatments for non-healing wounds aim to address the common deviations in healing mechanisms, mainly inflammation, inadequate angiogenesis and reduced synthesis of extracellular matrix. In this context, regenerative medicine strategies, i.e., platelet rich plasmas and mesenchymal stromal cell products, may form part of adjuvant interventions in an integral patient management....

Adjuvant systemic therapies in breast cancer.

Although some women with early breast cancer (BC) may be cured with loco-regional treatment alone, up to 20% of patients with early-stage BC will ultimately experience treatment failure and recurrence. A substantial portion of the success in improving clinical outcomes of patients with BC is related to the standardized use of adjuvant therapies. The identification of tumor subtypes with prognos...